Drreddys Laboratories | RDY - Capital Ordinário





Capital Ordinário Alterar Data
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bayer EUR 982.42M 0 2025-12
Canopy Growth CAD 368.28M 35.9M 2025-12
Cipla INR 807.77M 807.43M 2025-09
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Drreddys Laboratories INR 832.57M 53K 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Novartis USD 1.91B 60K 2026-03
Pacira USD 39.31M 1.81M 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.32M 765K 2025-12
Richter Gedeon HUF 179.35M 0 2025-12
Sun Pharmaceuticals INR 2.4B 35K 2025-09
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Teva Pharmaceutical Industries USD 1.16B 16.72M 2026-03